How GLP-1 medicines affect patients with pancreatic cysts
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how GLP-1 receptor agonist medicines (commonly used for diabetes or weight loss) affect a type of pancreatic cyst called IPMN. If you have IPMN and take this type of medicine, your data may help doctors understand whether it changes the cyst's behavior.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- A specific type of pancreatic cyst called IPMN was found on a scan.
- You are being treated with a GLP-1 receptor agonist (like Ozempic or similar).
- You give permission for researchers to use your medical records for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether blood markers can help predict which pancreatic IPMNs are likely to become cancerous. If successful, it could help doctors decide when surgery is needed.
This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.
This trial looks for markers in cyst fluid and tissue to help identify which IPMN growths are becoming invasive (spreading). It may help doctors decide who needs surgery.
This study follows patients with a type of pancreatic cyst called IPMN who receive the LINFU procedure, a treatment that uses sound waves and microbubbles. Researchers want to see how well it works and monitor safety.
This trial tests a new way to treat pancreatic cysts called IPMNs by putting a needle through an endoscope into the cyst and delivering chemotherapy directly. The goal is to see if this approach is feasible and safe before a larger study.
This study follows people with small, low-risk pancreatic cysts to see if they can be safely monitored without surgery. It aims to confirm that watching these cysts closely is a good alternative to immediate treatment.
Hear when a new IPMN trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.